METH-2 silencing and promoter hypermethylation in NSCLC.
Dunn JR, Panutsopulos D, Shaw MW, Heighway J, Dormer R, Salmo EN, Watson SG, Field JK, Liloglou T.
Dunn JR, et al. Among authors: watson sg.
Br J Cancer. 2004 Sep 13;91(6):1149-54. doi: 10.1038/sj.bjc.6602107.
Br J Cancer. 2004.
PMID: 15328519
Free PMC article.